type full_text History And Physical Findings [REDACTED][REDACTED][REDACTED_PASSPORT]85 year old Chinese Lady Allergic toÂ Ketoprofen: rash, Acarbose: whole body feeling hot.Vaccination: Influenza last given April 2020, Pneumococcal last give April 2019 I. CHIEF COMPLAINT History of present Illness 1. abd discomfort on day of admissionÂ vomited once 1 day before admissionÂ frequent loose stools since 1 day before admissionÂ passing small amount each timeÂ slight SOB on and off usually on exertion no PND/orthopneano feverno URTINo travel History I. PREMORBID STATUS A. FUNCTION ADL IndependentHome bound ambulant since COVID, not using walking aiddually continentswallowing intacthas Vision impairment myopia on eye glasshas hearing impairment bilateral on hearing aids B. FALLS HISTORY Nil C. SOCIAL HISTORY non smoker and no alcohol drinkerstays with son, no helper II. COGNITIVE HISTORY Â no difference in memory since last discharge (IFA done 29/3/20) III. PAST MEDICAL HISTORY 1. T 2 DM Â complicated by DM nephropathy baseline Cr 216 to 245 April admÂ HbA1c 7.2 April 2020Â 2. HTNÂ 3. HLDÂ 4. Ischaemic cardiomyopathy, HFrEF Â Hx of NSTEMI (2008)Â Coros (Feb 2008): Mid to distal LM 90 , pLAD 25 , ostium D 1 75 , mid RCA 75 Â s/p CABG x 3 (Feb 2008, LIMA LAD, SCG OM 1, SVG RPDA)Â 2 D Echo (16/10/13): LVEF 35 . RWMA consistent with IHD (multi vessel territory). Grade 1 diastolic dysfunction. Â 5. Autoimmune hepatitis Â Liver biopsy (16/7/09): Features in keeping with a lobular hepatitis with confluent necrosis and bridging fibrosis. Differential diagnosis includes autoimmune hepatitis. A drug or infectious related etiology should be excluded.Â ANA 1/400, Anti SMA >/ 1/400Â Hep B/C negative Â US Abdomen Mar 2019: Coarse nodular liver echotexture with irregular outline, stable calcified focus in segment 7, gallstonesÂ complicated by thrombocytopenia 87 to 140Â 6. Hyperthyroidism ?toxic MNGÂ Presented with hand tremos, increased appetite, weight lossÂ Â TRAb 0.6 2013 Â Previous thyroid scan Jul 2013 in SGH: Large hot nodule in right thyroid lobe, smaller hot nodule in left lobe. Â Previously f/u SGH Endo then d/c to NHGPÂ on carbimazoleÂ 7. OsteopaeniaÂ 8. Frequent headachesÂ Previously on follow up with NeuroÂ CT brain Feb 2001: focal scalloped area measuring ~1 cm in diameter in superior aspect of right frontal bone close to vertex, sclerotic margins, no intracranial lesion seenÂ Given open date neuro, referred for psychiatry opinionÂ 9. Dec 2019: Cervicogenic headache, complicated by fallÂ MRI brain stroke protocol: no acute strokeÂ 10. Chronic non specific right distal LL numbness (Resolved)Â Subjective increase in RLL weakness and heaviness Â MRI lumbar spine: lumbar spondylosis and DDDÂ Vit B 12 and folate repleteÂ NCS: bilateral mild chronic active S 1 radiculopathies, no electrodiagnostic evidence of peripheral sensory neuropathyÂ 11. HFrEF, CKD Stage 3 B titrated lasix from 40 mg BD to 60 mg OMÂ 12.Â GoutÂ recurrent flares: right MTPJ > left big toeÂ flare ppt by high dose frusemideÂ 13. Lytic lesion in right parietal bone likely dermoid cyst Â last Admission 29 March to 23 April under GRM:Â 1. Fluid overload lasix 60 mg OMÂ 2. GERD resolvedÂ 3. New onset AflutterÂ CHA 2 DS 2 VASc 7 (9.6 yearly risk of stroke) HAS BLED 5Â d/w pt and family re anticoagulation risk vs benefit explainedÂ Family and patient agree for warfarin initiation dc with 2 mg dailyÂ on warfarinÂ 4. NCNC anemia Hb ~10Â iron 9, transferrin 1.9, iron sat 20, ferritin 140Â normal B 12/folate Â Meds:Â Warfarin 2 mg MWFSÂ Warfarin 1.5 mg TTSÂ Carvedilol 25 mg BDÂ Carbimazole 2.5 mg OMÂ Linagliptin 5 mg OMÂ Glipizide 5 mg OMÂ atorvastatin 10 mg OMÂ Ca/Vit D 1 tab OMÂ Neurobion 1 tab OMÂ ISMN 30 mg BDÂ Omprazole 40 mg OMÂ Lasix 80 mg BDÂ Span K 600 mg on alernate days CURRENT ADMISSION: A. Management at ED: AfebrileSBP: 114 to 121 HR: 86 to 93 spo 2: 98 RAHC 3.4 > 3.8 given glucose drink in EC counter, D 10 500 ml 8 Hrsgiven Piptazo B. Initial Investigations: TW 4.9 Hb 11.2 (MCV 102 MCH 33 baseline Hb 10.3 10.4) Plt 146 CRP 0.6, procal 0.17 Na 141 K 3.8 Cr 250 (baseline 216 240) U 32.4 Trop I 19 BNP 1862 < 1298 last admission CXR: No focal consolidation is noted. Small bilateral pleural effusions are present. Old left lower rib fractures are noted. INR 3.4 C. Initial examination at Ward: afebrileBP 125/70 HR 70 SPO 2 100 on RA HC 4.8 5.3 alert, non toxicJVP elevated at mid neck heart s 1 s 2 no murmurslungs: bilateral basal creps left > rightabdomen: soft NT, BS( ) calves: supple no pedal edema ISSUES AND PROGRESS A. MEDICAL 1. Gastroenteritis likely viral held off abx started on Lacteolforte subsequently bowels cleared gently with laxatives in view of fecal loading Stool culture no pathogens AXR Mild faecal loading is seen COVID swabs negative,Â done x 2Â in view of CXR finding of Small bilateral pleural effusions 2. AoCKD with hypocalcemia, hypomagnasemia possibly 2' volume depletion from GI losses, contributed by lasix noted Lasix was recently increased from 60 mg BD to 80 mg BD at HF clinic Crea on admission 250 , downtrended to 240 Lasix initially witheld as patient weight dropped to 41.8 kg (baseline dry weight 46 47 kg) subsequently Lasix restarted once weight uptrended, GI losses resolved new baseline dry weight 43 44 kg weight upon discharge 43 kg patient discharged onÂ Frusemide 60 mg BD, with minimal bibasal creps but comfortable 3. Hypoglycemia episodeÂ in ED (from vomiting) OHGA stopped and switched to SCSI subsequently restarted Glipizide and Linagliptin old dose 4. Thrombocytopenia secondary to acute illnessb/g of chronic thrombocytopenia, autoimmune hepatitis baseline platelet 110 140 when well platelet drop to 72 dengue negative, PBF NAD witheld azathioprine and azathioprineÂ while platelet low subseqeutnyl platelets improved Plt on discharge 123 5. BG Atrial Flutter on Warfarin ACC reviewed inpatient Warfarin was witheld while platelet low subsequently restarted on old dose: PO Warfarin 2 mg Mon, Wed, Fri, Sun, 1.5 mg Tues, Thurs, Sat 6 pm 6. Hypotonic hyponatremia initially hypovolemic hyponatremia, Na 127, attributed to GI losses Na dropped further with clinical evidence of hypervolemia, Na 121 after fluid restriction and restarted Frusemide 60 mg BD, Na improved Na on discharge: 135 DISCHARGE STATUS A. Function PT faily independent ambulation, nid ailds, home wihout CGT, suggest for DRC after circuit breaker OT independent home ADLs, close to premorbid, no need CGT B. Discharge Destination: home withÂ son C. Change in Medications LasixÂ lower dose 60 mg BD withÂ potassium chlorideÂ 600 mg OMÂ started iron supplement (iron polymaltose)started Omeprazole 40 mg OM D. Follow ups TCU CVM ACC in 2 week, POCT INR on arrivalSGH Gastroenterology 22/9/20 follow up for autoimmune hepatitis, on azathioprineTTSH CVM 19/8/20 (heart failure clinic) for ischemic cardiomyopathy, titrating LasixTTSH Endocrine 22/7/20 follow up for hyperthyroidism with ?toxic MNG, on carbimazoleTTSH ENT 8/7/20 follow up for hearing impairment on hearing aidNew TTSH renal 15/7/20 referred during previous admission, for RRT discussionTTSH Ortho spine (Dr [REDACTED][REDACTED]) [REDACTED] [REDACTED][REDACTED] up for cervical spondylosis with cervical stenosisAMK OPS in 1 2 weeks to monitor Na, Plt, fluid status Outcome Followup Plan TCU CVM ACC in 2 week, POCT INR on arrivalSGH Gastroenterology 22/9/20 follow up for autoimmune hepatitis, on azathioprineTTSH CVM 19/8/20 (heart failure clinic) for ischemic cardiomyopathy, titrating LasixTTSH Endocrine 22/7/20 follow up for hyperthyroidism with ?toxic MNG, on carbimazoleTTSH ENT 8/7/20 follow up for hearing impairment on hearing aidNew TTSH renal 15/7/20 referred during previous admission, for RRT discussionTTSH Ortho spine (Dr [REDACTED][REDACTED]) [REDACTED] [REDACTED][REDACTED] up for cervical spondylosis with cervical stenosisAMK OPS in 1 2 weeks to monitor Na, Plt, fluid status